| Literature DB >> 34512730 |
Shushan Li1, Haitao Wang1, Yi Zhang1, Renqiu Qiao1, Peige Xia1, Zhiheng Kong1, Hongbo Zhao1, Li Yin1.
Abstract
BACKGROUND: Osteoarthritis (OA) is one of the most common age-related degenerative diseases. In recent years, some studies have shown that pathological changes in the synovial membrane occur earlier than those in the cartilage in OA. However, the molecular mechanism of synovitis in the pathological process of OA has not been elucidated. This study aimed to identify novel biomarkers associated with OA and to emphasize the role of immune cells in the pathogenesis of OA.Entities:
Keywords: GEO; bioinformatics; diagnostic markers; immune cell infiltration; osteoarthritis
Year: 2021 PMID: 34512730 PMCID: PMC8430221 DOI: 10.3389/fgene.2021.721258
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Workflow of the entire study.
FIGURE 2Functional enrichment of the differentially expressed genes (DEGs) in the synovial membrane and cartilage samples. (A,B) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment and Gene Ontology (GO) analysis of the DEGs in synovial membrane samples. (C,D) KEGG pathway enrichment and GO analysis of the DEGs in cartilage samples.
FIGURE 3Screening of hub genes and functional analysis. (A) Twenty-one differentially expressed genes (DEGs) intersected between the cartilage samples and the synovial membrane samples. (B) Protein–protein interaction (PPI) network of the 21 DEGs and two hub genes screened by the degree method (degree > 4) using cytoHubba. A higher ranking is represented by a redder color. (C) MMP9 and COL3A1 interacting genes indicated using Funrich software. (D) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of MMP9 and COL3A1 interacting genes.
Signaling pathway enrichment of MMP9 and COL3A1 interacting genes.
| ID | Description |
| Count | |
| hsa04151 | PI3K–Akt signaling pathway | 4.70E–11 | 6.11E–10 | 14 |
| hsa04512 | ECM–receptor interaction | 9.39E–18 | 8.55E–16 | 13 |
| hsa05146 | Amoebiasis | 7.07E–17 | 3.22E–15 | 13 |
| hsa04933 | AGE–RAGE signaling pathway in diabetic complications | 2.89E–15 | 8.77E–14 | 12 |
| hsa04510 | Focal adhesion | 1.38E–11 | 2.09E–10 | 12 |
| hsa05165 | Human papillomavirus infection | 4.48E–09 | 4.53E–08 | 12 |
| hsa04926 | Relaxin signaling pathway | 2.35E–12 | 5.35E–11 | 11 |
| hsa04974 | Protein digestion and absorption | 7.43E–12 | 1.35E–10 | 10 |
| hsa05205 | Proteoglycans in cancer | 1.11E–07 | 1.01E–06 | 9 |
| hsa05222 | Small cell lung cancer | 2.97E–09 | 3.38E–08 | 8 |
| hsa04657 | IL–17 signaling pathway | 2.19E–06 | 1.81E–05 | 6 |
| hsa05323 | Rheumatoid arthritis | 3.88E–05 | 0.000295 | 5 |
| hsa04060 | Cytokine–cytokine receptor interaction | 0.007225 | 0.034604 | 5 |
| hsa05206 | MicroRNAs in cancer | 0.008991 | 0.03896 | 5 |
| hsa05144 | Malaria | 5.26E–05 | 0.000368 | 4 |
| hsa05133 | Pertussis | 0.000271 | 0.001763 | 4 |
| hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 0.000772 | 0.004389 | 4 |
| hsa04668 | TNF signaling pathway | 0.00118 | 0.006314 | 4 |
| hsa04611 | Platelet activation | 0.001719 | 0.008692 | 4 |
| hsa04062 | Chemokine signaling pathway | 0.008221 | 0.037406 | 4 |
| hsa05219 | Bladder cancer | 0.000652 | 0.003953 | 3 |
FIGURE 4The landscape and correlation heatmap of immune infiltration in synovial membrane samples between the normal and osteoarthritis (OA) groups. (A) Relative distribution of 22 immune cells in all samples. (B) Correlation heatmap of immune cells in all samples. Red squares indicate positive correlation and blue squares indicate negative correlation; the deeper colored squares indicate stronger correlations.
FIGURE 5Characterization of immune cell infiltration in normal and osteoarthritis (OA) samples and the correlation between hub gene expression and immune cell infiltration. (A) Violin plot showing the differentially infiltrated immune cells of a proportion of the 22 immune cell types. The red underline shows significant difference in the immune cell infiltration between the normal and rheumatoid arthritis (RA) groups. A value of p < 0.05 was considered to be statistically significant. (B) Correlation coefficient (R) > 0.5; p < 0.05 was considered statistically significant.
FIGURE 6Validation of the hub genes (COL3A1 and MMP9) by quantitative reverse transcription PCR (qRT-PCR) and Western blotting. (A,B) Fragments per kilobase of exon model per million mapped fragments (FPKM) of COL3A1 and MMP9 in synovial membrane and cartilage samples. *p < 0.05; ****p < 0.001, unpaired Student’s t-test. (C,D) Gene expression levels of COL3A1 and MMP9 in non-osteoarthritic chondrocytes (NCH) and osteoarthritic chondrocytes (OA-CH) treated with different concentrations of IL-1β. (E–G) Western blotting was used to determine the protein expression levels of COL3A1 and MMP9 in NCH and OA-CH treated with different concentrations of IL-1β. Significant difference to control (NCH): #p < 0.05; ##p < 0.01; ###p < 0.001. *Significant difference between groups: *p < 0.05; **p < 0.01; ***p < 0.001. One-way ANOVA with Newman–Keuls multiple comparison test. All values represent the mean ± standard deviation (n = 4).